Moderna Stock Offering

Cambridge mass business wire may 18 2020 moderna inc.

Moderna stock offering. Has priced its stock offering to fund manufacturing of a coronavirus vaccine at 76 per share a person familiar with the matter said. Mrna a clinical stage biotechnology company pioneering messenger rna mrna therapeutics and vaccines to create a new generation of transformative medicines for patients today announced that it has commenced an underwritten public offering of 1 25 billion in shares of common stock. Mrna announced monday it is planning to raise more than 1 3 billion in a secondary public offering what happened the biotechnology company said it is offering 17 6 million. In addition moderna has granted the underwriters a 30 day option to purchase up to an additional 2 640 000 shares of common stock at the public offering price less underwriting discounts and.